Table 1.
Timepoint | Documentation | Special needs |
Treatment planning and radiotherapy | Basic data (see documentation form part 1) | |
Organ doses (see documentation form part 2) | 1. Dose-volume-histogram for lungs, heard, liver and kidneys, if in radiation field. Therefore CT-based treatment planning is mandatory if irradiation is performed to the thorax or abdomen. | |
2. Dosimetry of the thyroid gland if irradiation in head/neck area or mediastinum | ||
3. Dosimetry of the testes if irradiation is performed to the abdomen or to the upper part of the lower extremity | ||
6–8 weeks after end of radiotherapy Follow-up examination |
Documentation of maximal side effects that occured during or few weeks after radiotherapy according RTOG/EORTC criteria (see documentation form) | Only clinical examination |
1 year after end of radiotherapy: follow-up examination | Evaluation of late sequelae according to RTOG/EORTC criteria (see documentation form) | Only clinical examination, blood values to be asked from paediatricians |
2nd-10th (if feasible) year after radiotherapy follow-up examination 1×/year | Evaluation of late sequelae according to RTOG/EORTC criteria (see documentation form) | Only clinical examination, blood values to be asked from paediatricians |
The documentation forms have to be sent to the RiSK study trial center in Münster: RiSK-Study trial centre, Department of Radiotherapy, University Hospital of Münster, Albert-Schweitzer-Str. 33, D-48129 Münster, Germany, Phone: +49-251-83-47384, Fax: +49-251-83-47355, E-Mail: radtox@uni-muenster.de